Primary Immunodeficiency Disease News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Cancer Diagnosed More Often in Patients with Primary Immunodeficiency Diseases
Researchers evaluated the overall and site-specific incidence of cancer among patients registered in USIDNET, and found increased cancer incidence rates, especially in lymphomas, among patients with primary immunodeficiency diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 6, 2016 Category: Science Source Type: news
4th national workshop on primary immunodeficiency diseases inaugrated
The fourth national workshop on primary immunodeficiency diseases was inaugurated today at the Centrally sponsored JIPMER here. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 18, 2015 Category: Pharmaceuticals Source Type: news
Identified the epigenetic basis of CVID through the study of identic twins
(IDIBELL-Bellvitge Biomedical Research Institute) Researchers of the Chromatin and Disease Group from the Bellvitge Biomedical Research Institute (IDIBELL) and La Paz Hospital (IDIPAZ) have identified epigenetic alterations in Common Variable Immunodeficiency (CVID), the most common primary immunodeficiency, using as a starting point genetically identical monozygotic twins discordant for the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 17, 2015 Category: Global & Universal Source Type: news
Baxter introduces subcutaneous immunoglobulin treatment Hyqvia in US
Baxter International and Halozyme Therapeutics have announced the launch of Hyqvia in the US, a subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 21, 2014 Category: Pharmaceuticals Source Type: news
FDA approves Hyqvia to treat primary immunodeficiency
Baxter and Halozyme have received approval from the US Food and Drug Administration (FDA) for Hyqvia to treat adult patients with primary immunodeficiency (PI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 14, 2014 Category: Pharmaceuticals Source Type: news
Jeffrey Modell Foundation supports Belgian research on primary immunodeficiency
(VIB (the Flanders Institute for Biotechnology)) For the first time the Jeffrey Modell Foundation is giving a research grant to a Belgian laboratory. The team of Adrian Liston from VIB-KU Leuven will use the grant to develop a gene therapy to cure children that suffer from IPEX syndrome, a rare and fatal autoimmune disorder in which the immune system attacks the body's own tissues and organs. At the moment, the only successful therapy to treat the syndrome is a bone marrow transplantation, which is not available for all children. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 9, 2014 Category: Global & Universal Source Type: news
Baxter files modified BLA to FDA for HyQvia for treatment of primary immunodeficiency
Baxter International has filed an amended biologics license application (BLA) to the US Food and Drug Administration (FDA) to re-start the review process for approval of HyQvia facilitated subcutaneous infusion for the treatment of adult patients wit… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - December 5, 2013 Category: Pharmaceuticals Source Type: news
Human immune system shapes skin microbiome
Our skin plays host to millions of beneficial and potentially disease-causing microorganisms; however, whether our immune system influences these microbial communities to prevent disease is unknown. In a study published online in Genome Research, researchers have explored the microbes living on the skin of patients with primary immunodeficiencies with eczema-like skin conditions. The human body contains many microbes, some of which are necessary for healthy bodily functions including digestion. Others, such as some microbes living on our skin, may be pathogenic... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 30, 2013 Category: Consumer Health News Tags: Dermatology Source Type: news
GI Disorders in Patients With Primary ImmunodeficiencyGI Disorders in Patients With Primary Immunodeficiency
The gastrointestinal tract is the largest lymphoid organ in the body, so it is not surprising that intestinal diseases are common among immunodeficient patients. Clinical Gastroenterology and Hepatology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 7, 2013 Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Larger Vial Size Is Another Convenience Offering for People Managing Primary Immunodeficiency with Hizentra
KING OF PRUSSIA, Pa., Sept. 3, 2013 -- (Healthcare Sales & Marketing Network) -- CSL Behring today announced that the U.S. Food and Drug Adminis... Biopharmaceuticals, FDACSL Behring, Hizentra, Immune Globulin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 3, 2013 Category: Pharmaceuticals Source Type: news
Immunoglobulin Market (PI & CIDP ) Analysis and Forecasts to 2019...
“Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) potentially supplemented by approvals for Alzheimers disease” is...(PRWeb May 27, 2013)Read the full story at http://www.prweb.com/releases/immunoglobulin-market/pi-cidp-analysis-2019/prweb10772086.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 29, 2013 Category: Pharmaceuticals Source Type: news
Clinical Cases in Primary Immunodeficiency Diseases
A Problem-Solving ApproachPrimary immunodeficiency diseases (PIDs) are a heterogeneous group of inherited disorders characterized by different defects in the development and function of the immune system. These defects render patients susceptible to a variety of infectious diseases. Knowledge of normal immunity and specific warning signs and symptoms can help physicians to identify those children with underlying ... (Source: Springer Biomedical Sciences titles)
Source: Springer Biomedical Sciences titles - January 11, 2013 Category: Biomedical Science Tags: Immunology Source Type: news
